Approved comparison material connected to this topic.
6 total recordsSource comparisons are presented without a generated winner.
SS-31 (Elamipretide) Cardiolipin binding, cristae stabilisation Phase 2 trials in heart failure, mitochondrial myopathy (23–31% ATP improvement) 5–40 mg SC daily or 3×/week High. Selectively accumulates in inn…
| Documentation Method | Data Granularity | Audit Compliance | Real-Time Monitoring | Retrieval Speed | Implementation Cost | Professional Assessment ||—|—|—|—|—|—|| Paper logbook | Manual entry only, prone to…
Ischemia-reperfusion injury (rat heart) Infarct size reduction 3 mg/kg IV pre-ischemia 50–60% smaller infarcts vs saline; preserved cristae structure on electron microscopy Pre-treatment timing critical; post-…
Mechanism Cardiolipin binding + cristae stabilization Cardiolipin binding (if properly synthesized) Free radical scavenging only SS-31's structural mechanism is fundamentally different from scavenging. Antioxi…
Isolated cell monolayer (2D culture) 0.5–5 µM (0.5–5 mg/mL) 1–48 hours Direct addition to culture media Standard concentration range validated across multiple cell types; start at 1 µM for initial dose-respons…
MitoQ and SkQ1 use a triphenylphosphonium scaffold without defined cardiolipin binding — making SS-31 a distinct mechanistic tool for inner membrane research. See also: NAD+ research, longevity peptide researc…